Next Article in Journal
Novel Molecular Signatures Selectively Predict Clinical Outcomes in Colon Cancer
Next Article in Special Issue
Measurable Residual Disease Testing During Treatment with Bispecific Antibodies for Lymphoma
Previous Article in Journal
Assessing the Effect of Cytoreduction on Solitary, Resectable Lesions in Primary Central Nervous System Lymphoma
Previous Article in Special Issue
The Role of the Tumor Microenvironment in T-Cell Redirecting Therapies of Large B-Cell Lymphoma: Lessons Learned from CAR-T to Bispecific Antibodies
 
 
Article

Article Versions Notes

Cancers 2025, 17(6), 918; https://doi.org/10.3390/cancers17060918
Action Date Notes Link
article html file updated 31 August 2026 02:18 CEST Update https://www.mdpi.com/2072-6694/17/6/918/html
article html file updated 24 June 2025 19:19 CEST Update -
article html file updated 7 March 2025 08:56 CET Original file -
article pdf uploaded. 7 March 2025 08:54 CET Version of Record https://www.mdpi.com/2072-6694/17/6/918/pdf
article xml uploaded. 7 March 2025 08:54 CET Update https://www.mdpi.com/2072-6694/17/6/918/xml
article xml file uploaded 7 March 2025 08:54 CET Original file -
Back to TopTop